EPISODE SUMMARY

Have you lost GLP-1 coverage through your employer? Or maybe you never had it to begin with? In this episode, Amanda sits down with Jay Bregman, founder and CEO of Andel, to break down a real solution that exists right now. Andel is one of more than 18 vetted partners inside Eli Lilly’s Employer Connect program, and it is built differently from every other option on that list. No PMPM fees. No administrative overhead. No prior authorization. A membership fee under $10 per fill and a direct-to-employer price already lower than Lilly’s own cash pay option. Amanda shares the data on why employers dropped coverage in the first place, what it is actually costing them not to cover it, and what the research says about productivity, morale, and talent retention when employees have access or lose it. Plus exactly how to refer your own employer to the program in five minutes without waiting for HR to figure it out.

GUEST BIO

Jay Bregman is the founder and CEO of Andel, a healthcare technology platform enabling high-cost medications including GLP-1s to be accessible through employer benefits. A serial entrepreneur with 20-plus years of experience, he previously co-founded Hailo, the first pan-European ride-hailing company later acquired as Lyft Europe, and founded Thimble, acquired by S&P 500 insurer Arch Insurance.

Website: andel.org LinkedIn: linkedin.com/in/jaybregman Company: linkedin.com/company/joinandel

IN THIS EPISODE

[0:00] Jay’s background and how watching Senate drug pricing hearings sparked the idea

[3:30] What the word “andel” means and why the cooperative model is the foundation

[6:40] The Lilly Zepbound KwikPen direct-to-employer partnership explained

[13:00] The full confirmed pricing breakdown and what an employee actually pays

[17:00] Why the platform fee is the same for small and large employers

[19:00] How the employee experience works from app download to next-day delivery

[24:00] Employer ROI, productivity gains, and the business case

[29:00] The research on employees who lost GLP-1 coverage and what it showed

[33:00] Why Andel is expanding beyond GLP-1s to all high-cost employer drugs

[51:00] Nonprofit partnerships and the 5% profit fund for underserved patients

RESOURCES MENTIONED

Refer your employer now: andel.org/referral

Andel main site: andel.org

Andel on LinkedIn: linkedin.com/company/joinandel

Jay Bregman on LinkedIn: linkedin.com/in/jaybregman

Lilly Employer Connect launch announcement: fiercehealthcare.com/payers/eli-lilly-launches-its-direct-employer-platform-obesity-drugs

Lilly Direct cash pay pricing: lillydirect.com

Aon GLP-1 multi-year study: aon.com/en/insights/articles/workforce-focused-analysis-on-glp-1s

Kristi Turner episode — Lost GLP-1 Coverage Through Employer: glp1studio.substack.com/p/lost-glp1-coverage-through-employer

Jennifer Sansabrino episode — GLP-1 Coverage for Teens: glp1studio.substack.com/p/glp1-coverage-for-teens-one-moms-fight

GLP-1 Access and Contact Congress: glp1studio.substack.com/p/contact-congress-for-glp1-access

Obesity Action Coalition: obesityaction.org

STRONG Framework white paper: glp1strong.com

RELATED EPISODES

Lost GLP-1 Coverage Through Your Employer — Kristi Turner glp1studio.substack.com/p/lost-glp1-coverage-through-employer

GLP-1 Coverage for Teens — Jennifer Sansabrino glp1studio.substack.com/p/glp1-coverage-for-teens-one-moms-fight

Get full access to GLP-1 Studio at glp1studio.substack.com/subscribe